SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-100639
Filing Date
2024-09-17
Accepted
2024-09-17 15:32:09
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2424166d1_s3.htm S-3 160401
2 EXHIBIT 5.1 tm2424166d1_ex5-1.htm EX-5.1 10718
3 EXHIBIT 23.2 tm2424166d1_ex23-2.htm EX-23.2 3103
4 EX-FILING FEES tm2424166d1_ex107.htm EX-FILING FEES 12439
5 GRAPHIC tm2424166d1_ex23-1img001.jpg GRAPHIC 18588
6 GRAPHIC tm2424166d1_img001.jpg GRAPHIC 7799
7 GRAPHIC tm2424166d1_img002.jpg GRAPHIC 4039
8 GRAPHIC tm2424166d1_img003.jpg GRAPHIC 7915
9 GRAPHIC tm2424166d1_s3img01.jpg GRAPHIC 4049
  Complete submission text file 0001104659-24-100639.txt   247219
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282172 | Film No.: 241304000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)